Vikki L. Conway - 15 Nov 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Officer
Signature
/s/ Dov Bergwerk as attorney in fact for Vikki L. Conway
Issuer symbol
TEVA
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
16 Nov 2023, 07:36:02 UTC
Previous filing
05 Oct 2023
Next filing
01 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +33,482 $0.000000 33,482 15 Nov 2023 Ordinary Shares 33,482 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on November 15, 2023, with 8,370 vesting on each of November 15, 2024, November 15, 2025 and November 15, 2026, and 8,372 vesting on November 15, 2027.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.